Delivery Order SPE2DE24D0021-SPE2D626F187A
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $5,942.11 for Thermo Scientific DRI Fentanyl II drugs on November 14, 2025, with an ultimate completion date of November 20, 2025. This fixed-price contract with economic price adjustment was issued by the Department of Defense's Medical Supply Chain for delivery to Pittsburgh, Pennsylvania. The award carries no set-aside designation, indicating Fisher Scientific competed in an open procurement environment. As a child...
- This federal contract award, valued at $2,015.00, was issued by the Medical Supply Chain division of the U.S. Department of Defense to Fisher Scientific Company L.L.C., a for-profit limited liability company and major supplier of scientific products, equipment, and services to federal agencies. The contract is for the delivery of DRI FENTANYL II CTL 2X2X10MLRX medical supplies and was issued under a Delivery Order contract type with a Fixed Price with Economic Price Adjustment pricing structure....
- Fisher Scientific Company L.L.C. was awarded a $3,444.40 delivery order contract by the Department of Defense's Medical Supply Chain on July 22, 2025, for the procurement of an analytical profile kit for MedToxScan human urine testing. The contract, which is classified as a child award with no set-aside designation, is structured as a fixed-price delivery order with economic price adjustment provisions and will be performed in Pittsburgh, Pennsylvania. This award represents a continuation of...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,200 on August 4, 2025, by the Defense Medical Supply Chain to provide toxicology and drugs of abuse control reagents and supplies. This fixed-price contract with economic price adjustment carries an ultimate completion date of August 18, 2025, and will be performed in Pittsburgh, PA. The award represents a child contract under a larger vehicle structure and was made through open competition with no set-aside...
- The Defense Logistics Agency Troop Support Medical awarded a $299,250 delivery order to Fisher Scientific Company L.L.C. for controlled toxic drugs. The prime contractor will provide the requested products and services from August 11-24, 2023 in Pittsburgh, Pennsylvania under a fixed price with economic price adjustment contract. Fisher Scientific is a subsidiary of Thermo Electron Corporation Financial Services Division. No major subcontractors or set aside designations were indicated. This...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,821.12 by the Medical Supply Chain division of the Department of Defense, with an ultimate completion date of June 11, 2025. The contract, issued on June 6, 2025, is structured as a fixed-price delivery order with economic price adjustment provisions and involves the procurement of 4,568,468,875 units of approximately 99.9% pure acetyl Fisher chemistry in 4-liter glass bottles. The place of performance is located...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $2,481.25 by the Department of Defense's Medical Supply Chain for toxicology testing qualitative training and toxicology test select nine drug panel supplies. The delivery order, issued on October 29, 2025, is set to be completed by November 13, 2025, and will be performed in Pittsburgh, Pennsylvania. This award represents a child order under Fisher Scientific's existing single-award Blanket Purchase Agreement...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,238.44 on September 28, 2025, by the Medical Supply Chain, a defense-oriented federal agency. This fixed-price contract with economic price adjustment carries an ultimate completion date of October 1, 2025, and will be performed in Pittsburgh, Pennsylvania. The award represents a child contract under a larger contract vehicle and was executed through open competition with no set-aside designation, reflecting Fisher...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,386.30 by the Department of Defense's Medical Supply Chain on October 27, 2025, with an ultimate completion date of October 30, 2025. The contract, which carries no set-aside designation, operates under a fixed-price structure with economic price adjustment provisions and represents a child award under a larger indefinite delivery vehicle. The specific products being delivered under this order align with Fisher...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $1,282.38 by the Department of Defense's Medical Supply Chain on November 14, 2025, with an ultimate completion date of November 21, 2025. The delivery order, designated as a child contract under a larger vehicle, represents a routine procurement of scientific and laboratory supplies to support federal medical operations. This award was made without any set-aside designation, indicating open competition. Fisher...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D626F187ADelivery Order
Fisher Scientific Company L.L.C. received a delivery order award valued at $5,942.11 from the Department of Defense's Medical Supply Chain for Thermo Scientific DRI Fentanyl II drugs, with an ultimate completion date of November 21, 2025. This contract, awarded on November 14, 2025, operates under a fixed-price agreement with economic price adjustment provisions and carries no set-aside designation, indicating open competition. The award represents a child contract issued under a larger indefinite delivery vehicle, reflecting Fisher Scientific's role as an established federal supplier of laboratory reagents and diagnostic supplies supporting military medical operations. This delivery order aligns with Fisher Scientific's extensive portfolio of federal contracts serving the Department of Defense Medical Supply Chain and other federal health agencies. The company, headquartered in Pittsburgh, Pennsylvania, has demonstrated sustained capability in supplying specialized diagnostic equipment and pharmaceutical reagents to support federal healthcare and laboratory operations. The Fentanyl II drug reagent procurement reflects the military healthcare system's ongoing need for controlled substance testing and quality assurance materials to support toxicology and pharmaceutical operations across Defense medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 11/14/25 |